leisure time -WSS

leisure time

author：explore 2025-09-03 11:50:18 - browse：3

Who gets to sue the FDA? Is pharma caught in a trade war? And what does “AF” stand for?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Sarah Owermohle joins us to explain the Supreme Court case that could have dramatic effects on access to medication abortion — and the development of new medicines. We also discuss the latest news in the life sciences, including a contrarian take on a new obesity treatment, a congressional effort to ban Chinese biotech companies, and how we managed to make 300 episodes of this podcast.

For more on what we cover, here’s the latest on the mifepristone case; here’s where you can find Adam’s newsletter; here’s more on WuXi and Congress; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： The best solution to the drug shortages problem

hotspot

WSS

My daughter's legacy lives on through her writing, phage therapy

Naloxone nonprofit donates 200,000 doses after FDA approval

'Essentially witchcraft:' A former naturopath takes on the field

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

The system is set up to fail children with medical complexity

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

hotspot

leisure time

explore

Alkermes shareholders re

Q&A: Figuring out how songbirds sing may lead to better understanding of how humans learn

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Anavex keeps shifting the goalposts in its clinical trials

Tori Bowie and the unacceptable rates of Black maternal death

Pharma companies must ensure equitable access to obesity drugs

Psychedelics group wrestles with new pharma identity

Why failed clinical trials don’t always spell doom for a new drug

BioMarin wins approval for gene therapy to treat hemophilia A

Man killed during FBI raid in connection with threats against Biden, other officials

explore

Emergent cuts jobs, executive role in business shake

Curing rare childhood diseases will falter unless Congress steps up

Readers discuss the intersection of pregnancy and addiction

Study: Why relieving medical debt did not improve financial outcomes

The best solution to the drug shortages problem

How to use technology to prevent future drug shortages

hotspot

focus

hotspot

hotspot